Abstract:A fast clearing hydrophilic near-infrared (NIR) dye ICG-Der-02 was used to constitute tumor targeting contrast agents. Cell adhesion molecule integrin av beta 3 served as the target receptor because of its unique expression on almost all sprouting tumor vasculatures. The purpose of this study was to synthesize and compare the properties of integrin av beta 3-targeted, fast clearing NIR probes both in vitro and in vivo for tumor diagnosis. ICG-Der-02 was covalently conjugated to three kinds of RGD peptide including linear, monoeric cyclic and dimeric RGD to form three RGD-based NIR probes. The integrin receptor specificities of these probes were evaluated in vitro by confocal microscopy. The dynamic bio-distribution and elimination ratse were in vivo real-time monitored by a near-infrared imaging system in normal mice. Further, the in vivo tumor targeting abilities of the RGD-based NIR probes were compared in av beta 3-positive MDA-MB-231, U87MG and alpha(v)beta 3-negtive MCF-7 xenograft mice models. Three RGD-based NIR probes were successfully synthesized with good optical properties. In vitro cellular experiments indicated that the probes have a clear binding affinity to alpha(U)beta 3-positive tumor cells, with a cyclic dimeric RGD probe owing the highest integrin affinity. Dynamic bio-distributions of these probes showed a rapid clearing rate through the renal pathway. In vivo tumor targeting ability of the RGD-based porbes was demonstrated on MDA-MB-231 and U87MG tumor models. As expected, the c(RGDyK)2-ICG-Der-02 probe displayed the highest tumor-to-normal tissue contrast. The in vitro and in vivo block experiments confirmed the receptor binding specificity of the probes. The hydrophilic dye-labeled NIR probes exhibited a fast clearing rate and deep tissue penetration capability. Further, the alpha(U)beta 3 receptor affinity of the three RGD-based NIR probes followed the order of dimer cyclic > monomer cyclic > linear. The results demonstrate potent fast clearing probes for in vivo early tumor diagnosis. Copyright (c) 2012 John Wiley & Sons, Ltd.

Fluorescent RGD-based Pro-Apoptotic Peptide Conjugates As Mitochondria-Targeting Probes for Enhanced Anticancer Activities.

Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z ) for Near Infrared Fluorescence Imaging of Cancer

Super-sensitive Bifunctional Nanoprobe: Self-assembly of Peptide-Driven Nanoparticles Demonstrating Tumor Fluorescence Imaging and Therapy

Fabrication of self-assembled peptide nanoparticles for in vitro assessment of cell apoptosis pathway and in vivo therapeutic efficacy

Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells.

Hybridization of tumor homing and mitochondria-targeting peptide domains to design novel dual-imaging self-assembled peptide nanoparticles for theranostic applications

125I-Labeled Octavalent-Rgd Peptide Fluorescent Nanoprobe for Dual SPECT and Optical Imaging of Integrin {alpha}v{beta}3 Receptors in Human Giloblastoma Xenografts

4-tert-butylphenoxy substituted phthalocyanine with RGD motif as highly selective one-photon and two-photon imaging probe for mitochondria and cancer cell

Mitochondria-Targeting Fluorescent Molecules For High Efficiency Cancer Growth Inhibition And Imaging

Smart pH-Sensitive Nanogels for Enhancing Synergistic Anticancer Effects of Integrin αvβ3 Specific Apoptotic Peptide and Therapeutic Nitric Oxide

Imaging Integrin Alpha(V)Beta(3) And Nrp-1 Positive Gliomas With A Novel Fluorine-18 Labeled Rgd-Atwlppr Heterodimeric Peptide Probe

Imaging Integrin α v β 3 and NRP-1 Positive Gliomas with a Novel Fluorine-18 Labeled RGD-ATWLPPR Heterodimeric Peptide Probe

Synthesis of Dimeric Cyclic RGD Based Near-Infrared Probe for in Vivo Tumor Diagnosis

Optimization of a MT1-MMP-targeting Peptide and Its Application in Near-infrared Fluorescence Tumor Imaging

18F Labeled RGD‐A7R Peptide for Dual Integrin and VEGF‐targeted Tumor Imaging in Mice Bearing U87MG Tumors

RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.

Design of an Acidic pH‐Activated NIR Fluorescent Convertible Rhodamine−Hemicyanine Probe‐Peptide Conjugate for Living Cancer Cell Active Targeted Selective Tracking of Lysosomes

Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice

Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.

Synthesis of Fluorescene Labeled Peptide/Poly(Ether-Amide) with Targeting Function to Liver Cancer Cells

Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids